当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析

海尔生物

(688139)

  

流通市值:99.23亿  总市值:99.23亿
流通股本:3.18亿   总股本:3.18亿

海尔生物(688139)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年半年度实现净利润2.39亿元,每股收益0.74元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年半年度最新股东权益449756.70万元,未分配利润192788.75万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年半年度最新总资产558672.17万元,负债108915.46万元。

利润表
报告期2024-06-302024-03-312023-12-312023-09-30
营业总收入1,223,284,970.75686,909,061.522,280,896,019.231,826,339,651.43
营业总成本979,179,228.79538,737,974.71,966,937,346.461,528,552,037.64
营业利润256,790,390.69154,276,662.98438,401,339.39395,179,711.38
利润总额258,868,887.07154,701,391.69434,491,209.43391,622,464.17
净利润239,137,127.93141,852,238.97412,058,658.76365,645,845.17
其他综合收益-24,452,127.4212,754.54-43,521,492.11-30,515,814.23
综合收益总额214,685,000.51141,864,993.51368,537,166.65335,130,030.94
资产负债表
报告期2024-06-302024-03-312023-12-312023-09-30
流动资产合计2,405,604,989.662,748,960,813.132,536,028,043.522,636,531,294.08
非流动资产合计3,181,116,685.132,937,874,816.022,989,654,525.152,855,835,677.94
资产总计5,586,721,674.795,686,835,629.155,525,682,568.675,492,366,972.02
流动负债合计936,632,024.16987,889,894.8941,663,492.8916,478,213.35
非流动负债合计152,522,625.35142,448,597.74144,056,077.15158,545,718.83
负债合计1,089,154,649.511,130,338,492.541,085,719,569.951,075,023,932.18
归属于母公司股东权益合计4,254,327,364.484,342,842,117.064,230,710,929.54,207,513,559.88
股东权益合计4,497,567,025.284,556,497,136.614,439,962,998.724,417,343,039.84
负债和股东权益合计5,586,721,674.795,686,835,629.155,525,682,568.675,492,366,972.02
现金流量表
报告期2024-06-302024-03-312023-12-312023-09-30
经营活动现金流入小计1,088,512,990.31560,317,919.652,434,712,610.551,815,303,786.83
经营活动现金流出小计1,029,236,956.55483,112,922.832,185,448,075.961,647,807,501.6
经营活动产生的现金流量净额59,276,033.7677,204,996.82249,264,534.59167,496,285.23
投资活动现金流入小计1,296,735,713.19384,384,067.115,579,852,006.134,714,330,619.04
投资活动现金流出小计1,294,636,967.71391,913,472.065,327,095,930.884,361,360,720.01
投资活动产生的现金流量净额2,098,745.48-7,529,404.95252,756,075.25352,969,899.03
筹资活动现金流入小计10,250,0005,170,00011,895,0008,395,000
筹资活动现金流出小计202,206,159.4325,666,108.43180,194,490.64177,498,644.4
筹资活动产生的现金流量净额-191,956,159.43-20,496,108.43-168,299,490.64-169,103,644.4
汇率变动对现金及现金等价物的影响2,036,804.431,245,666.7-8,238,268.42-6,078,181.47
现金及现金等价物净增加额-128,544,575.7650,425,150.14325,482,850.78345,284,358.39
期末现金及现金等价物余额1,128,101,988.441,307,071,714.341,256,646,564.21,276,448,071.81
最新报告期:2024-09-15
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华创证券郑辰,李婵娟1.561.932.342024-09-15
中信证券宋硕,陈竹1.581.932.322024-09-10
东海证券杜永宏1.541.892.262024-08-27
华西证券王睿,崔文亮1.541.932.382024-08-27
西南证券杜向阳1.562.002.392024-08-25
TOP↑